EU proposal may accelerate pharma innovation decline, industry group says
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-proposal-may-accelerate-pharma-innovation-decline-industry-group-says-2023-11-06/
Medication was the single biggest contributor to the EU’s trade surplus, with 235 billion euro ($252 usd) worth of exports in 2021.
"Everyone, going forward, will start conducting trials in the U.S....In some cases, they (the medicines) are not going to developed in Europe," Jorgensen said, adding that the U.S. offers a major market after one approval process versus country-by-country in the EU.
KingDings [Michigan] /
npub17f…vnxhj
2023-11-11 15:03:45
Author Public Key
npub17f7yv3c587zyk83afnlxg8xgtn9j3apfcspx83kp68t5ve7ygxuqcvnxhjPublished at
2023-11-11 15:03:45Event JSON
{
"id": "4f5f695ce5d01b6ea4416bd647ce790100583fc2bb5a9313b1ca3be7bfdef6da",
"pubkey": "f27c4647143f844b1e3d4cfe641cc85ccb28f429c40263c6c1d1d74667c441b8",
"created_at": 1699715025,
"kind": 1,
"tags": [
[
"proxy",
"https://noagendasocial.com/users/KingDings/statuses/111392523879387226",
"activitypub"
]
],
"content": "EU proposal may accelerate pharma innovation decline, industry group says\nhttps://www.reuters.com/business/healthcare-pharmaceuticals/eu-proposal-may-accelerate-pharma-innovation-decline-industry-group-says-2023-11-06/\n\nMedication was the single biggest contributor to the EU’s trade surplus, with 235 billion euro ($252 usd) worth of exports in 2021.\n\n\"Everyone, going forward, will start conducting trials in the U.S....In some cases, they (the medicines) are not going to developed in Europe,\" Jorgensen said, adding that the U.S. offers a major market after one approval process versus country-by-country in the EU.",
"sig": "7df1d98d3b6f6ee8736ed168a44635eb7abb04d84367a380e80534b76ed54b4a67d6cda05b66b91fd35ce1e918dbe15950dd6fe0638be071f315c84488f7744a"
}